Paper4131883
Coronary care for myocardial infarction in diabetics.
Soler NG and 5 others. Lancet, 1974. Cited by 126 papers, by iCite.
Cite this record
ConductScience Library. Coronary care for myocardial infarction in diabetics. Papers, record 4131883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4131883
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Complications | Major topic |
| Myocardial Infarction | Major topic |
| Administration, Oral | |
| Aged | |
| Blood Glucose | |
| Coronary Care Units | |
| Death, Sudden | |
| Diabetes Mellitus | |
| Diet Therapy | |
| Female | |
| Humans | |
| Hypoglycemic Agents | |
| Insulin | |
| Length of Stay | |
| Male | |
| Middle Aged | |
| Ventricular Fibrillation |
Source PubMed
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 126 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36505353 | Validity of regional network systems on reperfusion therapy in diabetes mellitus and non-diabetes mellitus patients with ST-segment elevation myocardial infarction. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/36505353 | PubMed |
| 29225905 | Added sugars drive coronary heart disease via insulin resistance and hyperinsulinaemia: a new paradigm. | Open Heart | 2017 | https://conductscience.org/library/papers/29225905 | PubMed |
| 28545784 | Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence. | Trends Endocrinol Metab | 2017 | https://conductscience.org/library/papers/28545784 | PubMed |
| 26586275 | The Evidence for Saturated Fat and for Sugar Related to Coronary Heart Disease. | Prog Cardiovasc Dis | 2016 | https://conductscience.org/library/papers/26586275 | PubMed |
| 21088829 | Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: a population-based cohort study in Italy. | Eur J Clin Pharmacol | 2011 | https://conductscience.org/library/papers/21088829 | PubMed |
| 16029388 | The effects of glibenclamide, a K(ATP) channel blocker, on the warm-up phenomenon. | Ann Noninvasive Electrocardiol | 2005 | https://conductscience.org/library/papers/16029388 | PubMed |
| 14676228 | Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important? | Heart | 2004 | https://conductscience.org/library/papers/14676228 | PubMed |
| 11200307 | Beneficial and detrimental effects of intensive glycaemic control, with emphasis on type 2 diabetes mellitus. | Drugs Aging | 2000 | https://conductscience.org/library/papers/11200307 | PubMed |
| 10789825 | Comparative tolerability of sulphonylureas in diabetes mellitus. | Drug Saf | 2000 | https://conductscience.org/library/papers/10789825 | PubMed |
| 8739909 | Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing? | Diabetologia | 1996 | https://conductscience.org/library/papers/8739909 | PubMed |
| 7744216 | Cardiovascular effects of sulphonylurea derivatives. Implications for the treatment of NIDDM? | Diabetologia | 1995 | https://conductscience.org/library/papers/7744216 | PubMed |
| 7388561 | Policy for early discharge after acute myocardial infarction. | Br Med J | 1980 | https://conductscience.org/library/papers/7388561 | PubMed |
| 7042170 | Defective oxidation of drugs: pharmacokinetic and therapeutic implications. | Clin Pharmacokinet | 1982 | https://conductscience.org/library/papers/7042170 | PubMed |
| 7036621 | The effect of the acute administration of tolbutamide on left ventricular function in insulin-dependent diabetics. | Acta Diabetol Lat | 1981 | https://conductscience.org/library/papers/7036621 | PubMed |
| 6372249 | The heart in diabetes. | West J Med | 1984 | https://conductscience.org/library/papers/6372249 | PubMed |
| 4613418 | Longitudinal study of untreated chemical diabetes. | Br Med J | 1974 | https://conductscience.org/library/papers/4613418 | PubMed |
| 4052287 | Myocardial infarct size and mortality in diabetic patients. | Br Heart J | 1985 | https://conductscience.org/library/papers/4052287 | PubMed |
| 3928386 | Effects of various hypoglycaemic sulphonylureas on the cardiotoxicity of glycosides. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3928386 | PubMed |
| 3928081 | Effect of intravenous infusion of insulin in diabetics with acute myocardial infarction. | Br Med J (Clin Res Ed) | 1985 | https://conductscience.org/library/papers/3928081 | PubMed |
| 3298923 | Adverse cardiovascular effects of sulphonylurea drugs. Clinical significance. | Med Toxicol | 1987 | https://conductscience.org/library/papers/3298923 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4131883
GET https://conductscience.org/api/papers/v1/4131883/cited_by?page=2